DoveMed.com

Solitary Fibrous Tumor of Cervix

Article
Women's Health
Diseases & Conditions
+2
Contributed byKrish Tangella MD, MBASep 29, 2022

What are the other Names for this Condition? (Also known as/Synonyms)

  • Cervical SFT
  • Cervical Solitary Fibrous Tumor
  • SFT of Cervix 

What is Solitary Fibrous Tumor of Cervix? (Definition/Background Information)

  • Solitary Fibrous Tumor (SFT) of Cervix is a mostly benign (non-cancerous) overgrowth arising from the mesenchymal tissue
  • The mesenchyme is the middle layer of the 3 primary germ layers of an embryo, namely the ectoderm, mesoderm, and endoderm. The mesoderm gives rise to mesenchymal tissue, which is the source for bone, muscle, connective tissue, and dermis of skin
  • Solitary Fibrous Tumors are composed of fibroblasts and related cell types. These rare tumors can occur in any part of the body, or in the soft tissues, where mesenchymal cells are present. The tumor arises in the cervix as a mass
  • The cause of formation of the tumor is unknown. Currently, no known methods exist to prevent occurrence of the tumor
  • Most small tumors are asymptomatic, though the larger ones may compress the surrounding structures and cause related signs and symptoms. The diagnosis of Solitary Fibrous Tumor of Cervix can be confirmed through a tissue biopsy
  • The treatment is complete surgical removal of the tumor with adequate margins. Most Solitary Fibrous Tumors of Cervix are benign, however some show malignant behavior in terms of recurrence of the tumor after surgery, or metastasis (spread to distant parts of the body)
  • The prognosis of Solitary Fibrous Tumor of Cervix is dependent on whether the tumor can be completely removed through surgery or not

Who gets Solitary Fibrous Tumor of Cervix? (Age and Sex Distribution)

  • The Solitary Fibrous Tumor of Cervix can be present in women between 20 and 70 years of age, but is usually diagnosed in the fifth decade (between 40-50 years)
  • Though it is a rare tumor, it can occur worldwide and all races and ethnic groups may be affected

What are the Risk Factors for Solitary Fibrous Tumor of Cervix? (Predisposing Factors)

  • No clear-cut risk factors for Solitary Fibrous Tumor of Cervix have been established to date

It is important to note that having a risk factor does not mean that one will get the condition. A risk factor increases one's chances of getting a condition compared to an individual without the risk factors. Some risk factors are more important than others.

Also, not having a risk factor does not mean that an individual will not get the condition. It is always important to discuss the effect of risk factors with your healthcare provider.

What are the Causes of Solitary Fibrous Tumor of Cervix? (Etiology)

  • Currently, scientists do not know the factor(s) causing Solitary Fibrous Tumor of Cervix
  • Certain genetic mutations are have been detected. Research to characterize these mutations is currently underway

What are the Signs and Symptoms of Solitary Fibrous Tumor of Cervix?

The signs and symptoms depend on the size of the tumor. Solitary Fibrous Tumors can range in size from a few cm to up to 40 cm; though majority of the cervical tumors are less than 10 cm. They are usually slow-growing and form a single mass. The signs and symptoms associated with Solitary Fibrous Tumor of Cervix include:

  • Small tumors usually do not cause any symptoms. But, occasionally they may become painful, if they compress surrounding structure
  • Solitary Fibrous Tumors of Cervix may occur as slowly enlarging painless mass. The following symptoms may be seen:
    • Abnormal vaginal bleeding
    • Pain during and bleeding after intercourse
    • Menstrual cycle disturbances
    • Abnormal vaginal discharge
    • Anemia (due to bleeding)
    • Abdominal pain may occur
  • Rarely, these tumors, especially if large, may cause hypoglycemia
    • Hypoglycemia results in Doege-Potter syndrome, which occurs due to secretion of insulin-like growth factor-2 (IGF-2) by the tumor cells (paraneoplastic syndrome)
    • The signs and symptoms of hypoglycemia include confusion, altered mental status, sweating, dizziness, cold hands, etc.

How is Solitary Fibrous Tumor of Cervix Diagnosed?

The following procedures and tools may be used in the diagnosis of Solitary Fibrous Tumor of Cervix:

  • Evaluation of the individual’s medical history and a through physical examination
  • Plain X-ray of the abdomen
  • CT or CAT scan with contrast of the abdomen and pelvis usually shows a well-defined mass, which may have calcifications. This radiological procedure creates detailed 3-dimensional images of structures inside the body
  • MRI scans of the abdomen and pelvis: Magnetic resonance imaging (MRI) uses a magnetic field to create high-quality pictures of certain parts of the body, such as tissues, muscles, nerves, and bones. These high-quality pictures may reveal the presence of the tumor
  • Ultrasound scan of the abdomen
  • Solitary Fibrous Tumor of Cervix can additionally be evaluated using angiography of the abdomen and pelvic region
  • MRI scans and PET scans may help differentiate benign versus malignant SFTs by detecting areas of metastasis (if any)
  • Colposcopy:
    • The cervix is examined with an instrument, called a colposcope. This helps the physician get a magnified view of the cervix
    • In order for this procedure to be performed, the woman has to lie on a table, as for a pelvic exam. An instrument, called the speculum, is placed in the vagina to keep the opening apart, in order to help the physician visualize the cervix. The colposcope is then used to get a magnified view of the insides

Although the above modalities can be used to make an initial diagnosis, a tissue biopsy of the tumor is necessary to make a definitive diagnosis to begin treatment. The tissue for diagnosis can be procured in multiple different ways which include:

  • Fine needle aspiration (FNA) biopsy of the tumor: A FNA biopsy may not be helpful, because one may not be able to visualize the different morphological areas of the tumor. Hence, a FNA biopsy as a diagnostic tool has certain limitations, and an open surgical biopsy is preferred. Also, Solitary Fibrous Tumor is a fibrous tumor and FNA usually does not reveal many cells on a microscopic examination
  • Cervical core or cone biopsy of the tumor (colposcopic biopsy): The abnormal areas of the cervix are visualized with a colposcope. After numbing the cervix with a local anesthetic, an instrument, called a biopsy forceps, is used to get a tissue sample.  Mild cramps, pain, and some light bleeding, may occur following the procedure
  • Endocervical curettage (endocervical scraping): The curette is an instrument that can be used to scrape out tissue. Using a curette, cells are scraped out from the endocervix (the inner part of the cervix, close to the uterus/womb) and examined under a microscope. Mild pain and bleeding maybe present following the procedure
  • Cone biopsy or conization:
    • A cone-shaped piece of tissue is removed from the cervix during conization. The exocervix (the outer part) forms the base of this cone, while the endocervix (the inner part) forms the apex
    • The cone biopsy has the added advantage that it also serves as a treatment for pre-cancers and some early cancers
  • The following 2 methods can be used to obtain a cone biopsy specimen:
    • Loop electrosurgical procedure (LEEP, LLETZ): After numbing the area with a local anesthetic, a wire loop heated with electricity is used to remove a tissue specimen. This procedure, lasting about 10 minutes, may cause some cramping and mild-to-moderate bleeding, for a few weeks
    • Cold knife cone biopsy: This procedure is performed, either under general anesthesia or under spinal anesthesia. The tissue sample is removed using a surgical scalpel or through laser
    • Rarely, a complete excision of the uterus and cervix becomes necessary

Tissue biopsy:

  • A tissue biopsy of the tumor is performed and sent to a laboratory for a pathological examination. A pathologist examines the biopsy under a microscope. After putting together clinical findings, special studies on tissues (if needed) and with microscope findings, the pathologist arrives at a definitive diagnosis. Examination of the biopsy under a microscope by a pathologist is considered to be gold standard in arriving at a conclusive diagnosis
  • Biopsy specimens are studied initially using Hematoxylin and Eosin staining. The pathologist then decides on additional studies depending on the clinical situation
  • Sometimes, the pathologist may perform special studies, which may include immunohistochemical stains, molecular testing, and very rarely, electron microscopic studies to assist in the diagnosis

Many clinical conditions may have similar signs and symptoms. Your healthcare provider may perform additional tests to rule out other clinical conditions to arrive at a definitive diagnosis.

What are the possible Complications of Solitary Fibrous Tumor of Cervix?

Complications due to Solitary Fibrous Tumor of Cervix could include:

  • Hypoglycemia resulting in Doege-Potter syndrome, which occurs due to secretion of insulin-like growth factor-2 (IGF-2) by the tumor cells
  • Recurrence of SFT following surgery
  • Malignant transformation resulting in metastatic SFT
  • Complications may arise during chemotherapy and radiation therapy, due to the toxic medication or radiation effect

How is Solitary Fibrous Tumor of Cervix Treated?

There is no standard treatment protocol established for Solitary Fibrous Tumor of Cervix. However, in majority of cases, a complete surgical excision with clear or wide margins is the preferred mode of treatment, which can result in a cure, especially if it behaves in a benign manner.

The possible treatment measures for Solitary Fibrous Tumor of Cervix include the following:

  • Long-term follow-up is required, because recurrence at the site of surgery or metastasis in distant sites have been reported many years after surgery, even with tumors that behave benignly
  • Radical trachelectomy: The surgeon removes the cervix, upper part of the vagina, and nearby lymph nodes, while preserving the ability to have children
  • Hysterectomy: In this procedure, the uterus and cervix are removed. This is done by making an incision on the abdomen (termed abdominal hysterectomy), or through the vagina (termed vaginal hysterectomy), or by using a laparoscope (termed laparoscopic hysterectomy). Surgery is performed under general or epidural anesthesia, though the ability to have children is lost. Complications, such as bleeding, infection, or damage to the urinary tract, or the intestinal system may occur in rare cases
  • Radical hysterectomy: The uterus, cervix, the upper part of the vagina and tissues, next to the uterus are removed. Additionally, some pelvic lymph nodes may also be surgically taken out. The surgery is performed under anesthesia and may be carried out via an incision made on the abdomen or by using laparoscopy. With this invasive procedure, the ability to have children is lost. Rarely, complications such as bleeding, infection, or damage to the urinary tract or the intestinal system, may occur. Removal of lymph nodes may lead to swelling of legs (lymphedema)
  • Pelvic exenteration: The uterus, tissues surrounding the uterus, cervix, pelvic lymph nodes, and the upper part of the vagina, are removed. In addition, depending on the tumor spread, the remainder of the vagina, the bladder, rectum, and a part of the colon, may also be removed. Recovery from this surgery, takes a long period
  • Radiotherapy can be used as primary therapy in situations where the tumor cannot be removed completely, or when the tumor reappears (recurrent Solitary Fibrous Tumor of Cervix) after surgery
  • Radiotherapy for SFT can also be used as additional therapy after surgery, if there is a possibility of tumor recurrence after surgery, or if there are inadequate margins (possibility of tumor left behind) following surgery. In some cases due to location of tumor, a complete surgical removal of the tumor is difficult
  • Chemotherapy can be used for treating Solitary Fibrous Tumor of Cervix in following conditions:
    • When the tumors cannot be removed completely (due to incomplete surgical resection)
    • Tumors that recur after surgery (recurrent SFT of Cervix)
    • Tumors that have spread to distant parts of the body (metastatic SFT of Cervix)
  • Arterial embolization of Solitary Fibrous Tumor of Cervix is a possible treatment option. Here the blood supply to the tumor is blocked resulting in tumor death
  • Hypoglycemia due to the tumor is treated using corticosteroids
  • Post-operative care is important: One must maintain minimum activity levels, until the surgical wound heals

How can Solitary Fibrous Tumor of Cervix be Prevented?

  • Current medical research has not established a way of preventing Solitary Fibrous Tumor of Cervix formation
  • Regular medical screening at periodic intervals with blood tests, radiological scans, and physical examinations, for those who have already endured the tumor, are helpful

What is the Prognosis of Solitary Fibrous Tumor of Cervix? (Outcomes/Resolutions)

  • The most reliable prognostic factor of Solitary Fibrous Tumor of Cervix is dependent on whether the tumor can be completely removed through surgery with free margins (no traces of the tumor in adjoining tissue) or not
  • Current studies show that the tumor does not have any specific histologic feature (when a pathologist examines the tissue under a microscope), which can help in assessing a definite prognosis for the tumor
  • Individuals have an overall excellent survival rate following first complete surgical resection
  • Solitary Fibrous Tumor of Cervix that behave malignantly can lead to death
  • As with any tumor, it is important to have follow-up appointments with a physician to monitor for any returning tumors

The prognosis of Solitary Fibrous Tumors also depends upon a set of several factors, which include:

  • Stage of tumor: With lower-stage tumors, when the tumor is confined to site of origin, the prognosis is usually excellent with appropriate therapy. In higher-stage tumors, such as tumors with metastasis, the prognosis is poor 
  • The surgical respectability of the tumor (meaning, if the tumor can be removed completely) 
  • Overall health of the individual: Individuals with overall excellent health have better prognosis compared with those with poor health
  • Age of the individual: Older individuals generally have poorer prognosis than younger individuals
  • Whether the tumor is occurring for the first time, or is a recurrent tumor. Recurring tumors have worse prognosis compared to tumors that do not recur
  • Response to treatment: Tumors that respond to treatment have better prognosis compared to tumors that do not respond to treatment

An early diagnosis and prompt treatment of the tumor generally yields better outcomes than a late diagnosis and delayed treatment.

Additional and Relevant Useful Information for Solitary Fibrous Tumor of Cervix:

  • A tumor is an abnormal growth of tissue arising due to uncontrolled and rapid multiplication of cells that serve no function. They are also called neoplasms. Tumors can be benign or cancerous. A benign tumor may generally indicate no threat to one’s health; it also means that it is not “cancerous”
  • Grossly, Solitary Fibrous Tumor of Cervix is well-circumscribed but not encapsulated, and on cross-section appears gray white to yellow white in color
  • Microscopically, benign SFT exhibit alternation of hyper- and hypo- cellular areas, patternless pattern, keloid type collagen, and staghorn-shaped vessels-like areas
  • A pathologist may use special studies such as special stains. Special stains (markers) used on biopsy samples may include CD34, CD99, Vimentin, BCL-2. These stains help differentiate Solitary Fibrous Tumors of Cervix from other benign or cancer lesions
  • Although Solitary Fibrous Tumor can be classified as malignant based on the biopsy study (tumor greater than 5 cm, increased mitotic rate, necrosis, increased cellularity, or cytologic atypia, infiltrative growth, and weak CD34), these features cannot be absolutely correlated with regards to how it behaves, the nature of which may be aggressive, metastasis, or recurrent
  • Basic fibroblast growth factor (bFGF) labeling index and Ki-67 labeling index can be used for evaluation of benign versus malignant Solitary Fibrous Tumors of Cervix
  • Hemangiopericytoma (also known as Solitary Fibrous Tumor - Hemangiopericytoma type; or Cellular Solitary Fibrous Tumor) is closely related to SFT of Cervix, but is not identical to it. Many pathologists consider hemangiopericytoma and Solitary Fibrous Tumor as a continuum of tumors
Was this article helpful

On the Article

Krish Tangella MD, MBA picture
Approved by

Krish Tangella MD, MBA

Pathology, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!